CompareMarketResearchRequest a sample
Home / Healthcare / Patient Recruitment

Healthcare · Market report

Patient Recruitment Market Size, Share and Forecast 2026-2036

The global patient recruitment market is worth USD 5.2 bn in 2026 and is forecast to reach USD 12.4 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Site-based and site network recruitment is the largest by service segment.

USD 5.2 bnMarket size 2026
USD 12.4 bnForecast 2036
9.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global patient recruitment market is worth USD 5.2 bn in 2026 and is forecast to reach USD 12.4 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Site-based and site network recruitment is the largest by service segment.

ScopeServices that find, screen, enrol and retain participants for clinical trials, including digital outreach, site networks, patient registries, pre-screening and retention programmes.
IndustryHealthcare
Value 2025USD 4.8 bn
Value 2026USD 5.2 bn
Value 2036USD 12.4 bn
CAGR 2026-20369.0%
Volume 20261,026 thousand patients
Volume 20361,992 thousand patients
Average price 2026USD 5,100 per patient
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Patient Recruitment market size and forecast, 2026-2036

Exhibit 1The global patient recruitment market is forecast to grow from USD 5.2 bn in 2026 to USD 12.4 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 9.0%
Patient Recruitment market value, 2025 to 2036Market value by year. 2025: USD 4.8 bn; 2026: USD 5.2 bn; 2027: USD 5.7 bn; 2028: USD 6.2 bn; 2029: USD 6.8 bn; 2030: USD 7.4 bn; 2031: USD 8.1 bn; 2032: USD 8.8 bn; 2033: USD 9.6 bn; 2034: USD 10.4 bn; 2035: USD 11.4 bn; 2036: USD 12.4 bn. Compound annual growth rate 2026 to 2036: 9.0%.20255.2 bn20268.1 bn203112.4 bn20369.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 5.2 bn
2027USD 5.7 bn
2028USD 6.2 bn
2029USD 6.8 bn
2030USD 7.4 bn
2031USD 8.1 bn
2032USD 8.8 bn
2033USD 9.6 bn
2034USD 10.4 bn
2035USD 11.4 bn
2036USD 12.4 bn

Patient Recruitment market segmentation

By service

Exhibit 2Site-based and site network recruitment is the largest segment by service, with 30.0% of 2026 revenueEstimated share of 2026 global revenue, by service
Patient Recruitment market share by service, 2026Share of 2026 revenue by service. Site-based and site network recruitment: 30.0%; Digital and social media recruitment: 24.0%; Pre-screening, retention and engagement: 20.0%; Registry and database matching: 14.0%; Call centres and patient advocacy: 12.0%.Site-based and site network recruitment30.0%Digital and social media recruitment24.0%Pre-screening, retention and engagement20.0%Registry and database matching14.0%Call centres and patient advocacy12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Site-based and site network recruitment30.0%26.3%USD 1.6 bn7.6%
Digital and social media recruitment24.0%30.3%USD 1.3 bn11.6%
Registry and database matching14.0%13.5%USD 732 mn8.6%
Call centres and patient advocacy12.0%8.7%USD 628 mn5.6%
Pre-screening, retention and engagement20.0%21.1%USD 1.0 bn9.6%

By trial phase

Exhibit 3Phase III adds the most revenue by trial phase, growing from USD 2.5 bn in 2026 to USD 5.9 bn by 2036Estimated revenue in USD by trial phase, 2026 and 2036 forecast
Patient Recruitment market by trial phase, 2026 and 2036Revenue by trial phase in 2026 and 2036. Phase III: USD 2.5 bn in 2026, USD 5.9 bn in 2036, change +133%; Phase II: USD 1.3 bn in 2026, USD 3.1 bn in 2036, change +144%; Phase IV and post-marketing: USD 837 mn in 2026, USD 2.1 bn in 2036, change +155%; Phase I: USD 628 mn in 2026, USD 1.3 bn in 2036, change +112%.20262036 forecastChangePhase III+133%2.5 bn5.9 bnPhase II+144%1.3 bn3.1 bnPhase IV and post-marketing+155%837 mn2.1 bnPhase I+112%628 mn1.3 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Phase I12.0%10.8%USD 628 mn7.8%
Phase II24.0%24.7%USD 1.3 bn9.3%
Phase III48.0%47.2%USD 2.5 bn8.8%
Phase IV and post-marketing16.0%17.3%USD 837 mn9.8%

By therapeutic area

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Oncology30.0%33.6%USD 1.6 bn10.2%
Neurology14.0%14.3%USD 732 mn9.2%
Cardiovascular and metabolic16.0%14.3%USD 837 mn7.8%
Infectious diseases10.0%7.8%USD 523 mn6.3%
Rare diseases12.0%14.7%USD 628 mn11.2%
Other18.0%15.3%USD 942 mn7.3%

By recruitment channel

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Digital and social media34.0%42.0%USD 1.8 bn11.3%
Site-based outreach26.0%22.0%USD 1.4 bn7.2%
Patient registries and databases20.0%18.0%USD 1.0 bn7.9%
Physician referral networks20.0%18.0%USD 1.0 bn7.9%

By trial type

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Interventional drug trials58.0%54.0%USD 3.0 bn8.2%
Interventional device trials18.0%18.0%USD 942 mn9.0%
Observational studies24.0%28.0%USD 1.3 bn10.7%

Top 25 countries for patient recruitment by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 81.0% of 2026 revenue and the 25 countries below together hold 95.1%.

Exhibit 4United States is the largest country market at USD 2.2 bn in 2026, and the three largest countries hold 55.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Patient Recruitment market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 2.2 bn, 42.0%; China: USD 419 mn, 8.0%; United Kingdom: USD 262 mn, 5.0%; Germany: USD 262 mn, 5.0%; France: USD 209 mn, 4.0%; Japan: USD 209 mn, 4.0%; Canada: USD 209 mn, 4.0%; Spain: USD 157 mn, 3.0%; Italy: USD 157 mn, 3.0%; Australia: USD 157 mn, 3.0%.United States2.2 bn 42.0%China419 mn 8.0%United Kingdom262 mn 5.0%Germany262 mn 5.0%France209 mn 4.0%Japan209 mn 4.0%Canada209 mn 4.0%Spain157 mn 3.0%Italy157 mn 3.0%Australia157 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 2.2 bn42.0%USD 5.1 bn8.7%
2ChinaUSD 419 mn8.0%USD 1.3 bn12.2%
3United KingdomUSD 262 mn5.0%USD 570 mn8.1%
4GermanyUSD 262 mn5.0%USD 570 mn8.1%
5FranceUSD 209 mn4.0%USD 458 mn8.2%
6JapanUSD 209 mn4.0%USD 421 mn7.2%
7CanadaUSD 209 mn4.0%USD 483 mn8.7%
8SpainUSD 157 mn3.0%USD 372 mn9.0%
9ItalyUSD 157 mn3.0%USD 359 mn8.6%
10AustraliaUSD 157 mn3.0%USD 372 mn9.0%
11NetherlandsUSD 107 mn2.0%USD 256 mn9.2%
12SwitzerlandUSD 94 mn1.8%USD 225 mn9.2%
13BelgiumUSD 76 mn1.5%USD 185 mn9.2%
14SwedenUSD 70 mn1.3%USD 168 mn9.2%
15PolandUSD 64 mn1.2%USD 154 mn9.2%
16DenmarkUSD 56 mn1.1%USD 135 mn9.2%
17South KoreaUSD 46 mn0.9%USD 110 mn9.1%
18IndiaUSD 42 mn0.8%USD 102 mn9.3%
19BrazilUSD 36 mn0.7%USD 85 mn9.2%
20MexicoUSD 32 mn0.6%USD 78 mn9.2%
21IsraelUSD 28 mn0.5%USD 67 mn9.2%
22TaiwanUSD 25 mn0.5%USD 61 mn9.2%
23AustriaUSD 23 mn0.4%USD 56 mn9.2%
24ArgentinaUSD 20 mn0.4%USD 48 mn9.0%
25RussiaUSD 17 mn0.3%USD 40 mn9.0%
Rest of worldUSD 258 mn4.9%USD 633 mn9.4%
Exhibit 5United States and China account for 53% of the USD 7.2 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Patient Recruitment market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 5.2 bn. United States: +USD 2.9 bn; China: +USD 907 mn; United Kingdom: +USD 308 mn; Germany: +USD 308 mn; Canada: +USD 274 mn; 20 other countries: +USD 2.1 bn; Rest of world: +USD 374 mn. Market value 2036: USD 12.4 bn.Market value 20265.2 bnUnited States+2.9 bnChina+907 mnUnited Kingdom+308 mnGermany+308 mnCanada+274 mn20 other countries+2.1 bnRest of world+374 mnMarket value 203612.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • IQVIA
  • ICON
  • Syneos Health
  • Parexel
  • Thermo Fisher Scientific
  • Labcorp

Group 2: Regional and specialist players

  • Medpace
  • Fortrea
  • WCG
  • Elligo Health Research
  • Citeline
  • Advarra
  • Velocity Clinical Research
  • Care Access
  • TriNetX
  • Javara

Group 3: Emerging and niche players

  • Antidote Technologies
  • Clariness
  • Trialbee
  • SubjectWell
  • StudyKIK
  • Clara Health

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the patient recruitment market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.0% is calculated from the resulting values.

The market is divided by service, by trial phase, by therapeutic area, by recruitment channel, by trial type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the patient recruitment market?

The global patient recruitment market is estimated at USD 4.8 bn in 2025 and USD 5.2 bn in 2026.

How fast will the patient recruitment market grow?

It is forecast to reach USD 12.4 bn by 2036, a compound annual growth rate of 9.0% from 2026, an increase of USD 7.2 bn.

Which country is the largest market for patient recruitment?

United States is the largest market by revenue at USD 2.2 bn in 2026, 42.0% of the global total. The three largest countries together hold 55.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 12.2% a year from 2026 to 2036.

Which patient recruitment segment is largest?

In the by service split, Site-based and site network recruitment is the largest segment with 30.0% of 2026 revenue.

Who are the leading patient recruitment companies?

Global leaders include IQVIA, ICON, Syneos Health, Parexel.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← PET Imaging Workflow Patient-Matched Orthopedic Guides →

All Healthcare markets →

Request a sample